Patient care navigation and health copilot AI
Neatly Health
Neatly supports patient-selected records and sharing. Optional identifiable sharing must be distinguished from population insights. The review corrects blanket sharing claims and outdated caregiver-feature descriptions, while keeping source and correction gaps explicit.
Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.
Agency checklist · October 30, 2026
Mixed 7 of 12 yes
Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.
Assessed function: Patient-initiated recording, summaries and health questions, with separate cohort-insight commercialization and optional third-party opportunities.
A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.
- Public documents do not establish actual product behavior.
- The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
| Question | Answer | Evidence / review | Source and reasoning |
|---|---|---|---|
| 1. Told it is AI | Yes | documented Not independently replicated | neatly provides an AI-powered health companion to help you understand your care.Source Terms section 2. Privacy section 7 describes what 'Our AI' does. |
| 2. Operator and model maker named | No | not-documented Not independently replicated | We use trusted service providers for hosting, AI processing, and analytics.Source Neatly Health, Inc. is named. No AI model maker is named in the Privacy Policy, Terms, FAQ, About or App Store listing. |
| 3. Patient chooses to use it | Yes | documented Not independently replicated | Conversation recordings (doctor-patient visits you choose to record).Source Patient downloads and starts recording. Optional third-party 'opportunities' are opt-in. |
| 4. Patient sets the task | Yes | documented Not independently replicated | Yes! Chat with Neatly any time about your health for neutral guidance and support.Source Patient chooses recordings and questions. Operator has its own aims (cohort insights, optional trial recruitment, premium specialists), but these are not documented as steering the patient's task. |
| 5. Patient can decline or stop | Yes | documented Not independently replicated | Conversation recordings (doctor-patient visits you choose to record).Source Self-started: Q3 is yes and no care depends on using Neatly. Source is the Q3 source. Terms 11: 'You may stop using the service anytime.' |
| 6. Patient sees the AI output | Yes | documented Not independently replicated | Within minutes, you'll get a plain-language summary of what was discussedSource App Store listing: 'Read the full transcript whenever you want'. |
| 7. Patient can correct or challenge | Yes | documented Not independently replicated | If you find mistakes in the transcription or notes, contact us for help.Source Privacy section 7. Contact is a chat widget or message form. No self-serve edit is documented. |
| 8. Patient can get a copy | No | not-documented Not independently replicated | To make a request to access, delete, correct, or opt out, contact us at:Source An 'access' request is mentioned for state-law rights, but no export, download or copy is documented. Sharing summaries with caregivers is described as a feature. |
| 9. Patient can delete | Yes | documented Not independently replicated | If you want something deleted, just ask us and we'll remove it within 30 days.Source Closing the account deletes everything within 90 days. |
| 10. Training or sale does not override patient choice | No | documented Not independently replicated | Use your data in de-identified or aggregated form for research and commercial purposes.Source Terms section 4 license. No opt-out is offered for de-identified or aggregated use. FAQ says Neatly sells population insights to pharma. Training is not addressed. Identifiable sharing is opt-in only. |
| 11. Patient can run it or take it elsewhere | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. Source Vendor-hosted. No self-hosting or documented move-elsewhere route. |
| 12. No advertising or data business | No | documented Not independently replicated | We sell aggregated, de-identified insights to pharmaceutical and medical device companies.Source FAQ: 'We make money by selling population-based insights to pharmaceutical companies and other research organizations'. Marketing says individual data is never sold, which is consistent with the Terms. Optional opportunities may also share identifiable data with pharma or CROs with consent. |
Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.
Checklist rules · Independent review and limitations · Later evidence follow-up
Earlier v1.3 assessment and control finding
Historical assessment under different rules. It does not set the current checklist zone.
Agency finding, before method v1.3
Potentially agency-expanding, with data-commercialization caveat
Legacy editorial placement, pre-method: 82
This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.
- Evidence
- Documentary review. Public sources only, no hands-on testing by HugoScore.
- Review status
- AI draft. No person has settled the findings.
Earlier evidence and assessment
The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.
Earlier finding · Legacy editorial placement, pre-method: 82
Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 82. Not comparable with v1.3 positions.
Potentially agency-expanding, with data-commercialization caveat
Neatly supports patient-selected records and sharing. Optional identifiable sharing must be distinguished from population insights. The review corrects blanket sharing claims and outdated caregiver-feature descriptions, while keeping source and correction gaps explicit.
Patient agency
How this tool changes agency
A retained visit account can support questions and challenge misunderstandings. Cohort patterns are not necessarily comparable treatment evidence, and per-answer source links remain unverified.
Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved
Patient agency assessment
Who sets and changes the goal?
Patients initiate recording and questions and can reuse summaries. The public pass does not establish editable transcripts or control over all cohort-derived uses.
What can the patient understand, question, or do?
A retained visit account can support questions and challenge misunderstandings. Cohort patterns are not necessarily comparable treatment evidence, and per-answer source links remain unverified.
Can the patient evaluate the conditions of use?
The FAQ's blanket no-individual-sharing language needs the policy's explicit optional sharing exception. Sponsor non-influence is a vendor statement, not independently verified neutrality.
Text findings
Conditions of use
Published controls and their limits
The FAQ's blanket no-individual-sharing language needs the policy's explicit optional sharing exception. Sponsor non-influence is a vendor statement, not independently verified neutrality.
What remains unknown?
Not tested or not established
Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Earlier review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Earlier review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
Document-based draft · Moderate for public product and policy descriptions (AI-assisted draft)